No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Top Cited Papers
- 30 March 2020
- journal article
- letter
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 50 (4), 384
- https://doi.org/10.1016/j.medmal.2020.03.006
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus InfectionViruses, 2018
- Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesPharmacology Research & Perspectives, 2017
- Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral TherapyJAMA, 2012
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trialThe Lancet Infectious Diseases, 2011
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese AdultsPLoS Neglected Tropical Diseases, 2010